Castuner

OncoPharm

John Bossaer

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Podcast website

Listen in your app

Episodes

449 episodes

  1. ESMO 26 24:07
  2. Dostarlimab's Journey in MMRd Rectal Cancer 10:59
  3. Blinatumomab & Ponatinib for ALL 15:31
  4. HER2 Climb 05 13:34
  5. Lirafugratinib + LITESPARK011 15:34
  6. PI3K Pathway Hyperglycemia 10:07
  7. Neutropenic Diets & Lung Cancer Updates 14:18
  8. How to Read a Press Release and Drug Shortage Help 14:49
  9. Paradigm and Daraxonrasib in NSCLC 14:31
  10. Daraxonrasib, Zanidatamab, and CNS Lymphoma Updates 20:26
  11. Iberdomide 15:37
  12. Kidney Cancer in a Nutshell 16:12
  13. Small Cell Lung Cancer and CINV Updates 17:35
  14. Zidesamtinib & PPIs in Pacific 16:32
  15. Gedatolisib et al 18:16
  16. Endurance Part 2 15:12
  17. A Decade of CAR-T, Ocra-T, & POLARGO 19:18
  18. Breast Cancer Updates and T-Cell Stemness 19:23
  19. Updates on capivasertib, belzutifan, talquetamab, & durvalumab 19:32
  20. ASCO '26 25:38
  21. Pivekimab sunirine 13:49
  22. BCL2 & HER2 Targeting Agent Updates 13:45
  23. IMHOTEP, PJP, and more 9:59
  24. Vepdegestrant 11:35
  25. Targets Trop 2 12:41
  26. Promising Pancreatic Cancer Data 13:56
  27. ICI-Induced T1DM 13:24
  28. Relacorilant 15:13
  29. HOPA 2026 Recap 13:36
  30. Nivo-AVD Approval 9:32
  31. Tazemetostat Withdrawl and RECITE 14:47
  32. FDA Approval Updates Galore 12:47
  33. BR.31 & ASCO GU '26 18:00
  34. Rezatapopt and Colchicine for Trametnib/Dabrafenib Pyrexia 16:05
  35. Perioperative Enortumab vedotin + Pembrolizumab 16:30
  36. Axi-Cel and 5-FU Label Changes 12:34
  37. Core Communication Skills in Chemotherapy Education 15:27
  38. PATINA 15:44
  39. Sacituzumab govitecan + pembrolizumab and ASCO GI '26 17:50
  40. Oncology Drug Use Evolution 11:25
  41. 2025 New Drug Review 15:08
  42. Bladder Cancer Updates & SC Amivantamab 13:03
  43. ASH 2025 29:05
  44. DPYD Deficiency Testing 15:33
  45. Cornucopia of Autumn Updates 16:51
  46. PGYNone: Dandelion Effect 36:39
  47. PGY1 Pathway: Road Trip! 34:06
  48. PGY2 Pathway: A Planned City 32:57
  49. Tale from the Crypt: Belantamab Mafodotin 14:23
  50. ESMO 2025 24:43